THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Theophylline And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Theophylline And Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theophylline And Dextrose 5% In Plastic Container
A generic version of THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 122 |
| DailyMed Link: | THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Nebraska | PHASE1 |
| Minia University | EARLY_PHASE1 |
| Assiut University | PHASE1 |
See all THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
